7-Eleven Owner Reports Profit Drop, Keeps Guidance Unchanged
The 7-Eleven owner said Thursday that net profit fell 65% from a year earlier to 63.63 billion yen, equivalent to $401.3 million, for the nine months ended Nov. 30. Operating profit from all major ...
Correction to Novo Nordisk, Valo Health Article on Wednesday
Valo Health is eligible for a further $1.9 billion in potential milestone payments for up to nine new drug programs "Novo Nordisk, Valo Health Expand Drug Discovery and Development Pact -- Update," at ...
GSK in Talks to Buy U.S. Rare Tumor Specialist IDRx for up to $1 Billion, FT Says, Citing Sources
--Pharmaceutical giant GSK PLC is in talks to buy U.S. privately owned biotech company IDRx, which is developing a treatment for rare gastrointestinal tumors, for up to $1 billion, the Financial Times ...